Content about Collaborative Care

January 23, 2013

Health kiosk maker SoloHealth has joined a health program led by former president Bill Clinton, the company said Wednesday.

ATLANTA — Health kiosk maker SoloHealth has joined a health program led by former president Bill Clinton, the company said Wednesday.

January 22, 2013

The Food and Drug Administration has approved a generic contraceptive made by Lupin Pharmaceuticals, the drug maker said Tuesday.

BALTIMORE — The Food and Drug Administration has approved a generic contraceptive made by Lupin Pharmaceuticals, the drug maker said Tuesday.

Lupin announced the approval of levonorgestrel and ethinyl estradiol tablets in the 0.1 mg/0.02 mg strength, a generic version of Watson Labs' Lutera.

Lutera had sales of about $103.6 million during the 12-month period that ended in September 2012, according to IMS Health.

January 21, 2013

Eye care company Alcon has launched a treatment for pain and inflammation resulting from cataract surgery, the company said Monday.

NEW YORK — Eye care company Alcon has launched a treatment for pain and inflammation resulting from cataract surgery, the company said Monday.

The company said Ilevro (nepafenac) ophthalmic suspension was a nonsteroidal anti-inflammatory drug and once-daily treatment for cataract surgery patients.

January 21, 2013

Drug maker GlaxoSmithKline is seeking Food and Drug Administration approval for a new treatment for Type 2 diabetes, the drug maker said.

LONDON — Drug maker GlaxoSmithKline is seeking Food and Drug Administration approval for a new treatment for Type 2 diabetes, the drug maker said.

GSK announced the submission to the FDA of a regulatory approval application for albiglutide. The drug is not approved in any market yet, and the company plans to also seek approval in the European Union this year.

GSK assumed control of albiglutide with its $3.6 billion acquisition of Human Genome Sciences, announced last July.

January 21, 2013

While regulations for biosimilars work their way through the Food and Drug Administration, state governments are already looking at legislation concerning the substitution of biosimilars for their branded counterparts, according to a legal affairs blog focused on the FDA.

NEW YORK — While regulations for biosimilars work their way through the Food and Drug Administration, state governments are already looking at legislation concerning the substitution of biosimilars for their branded counterparts, according to a legal affairs blog focused on the FDA.

In a post Friday on FDA Law Blog, the official blog of the law firm Hyman, Phelps & McNamara, attorney Kurt Karst wrote that several states were laying the groundwork for such legislation, recalling state-level antisubstitution laws targeting generics that were adopted in the 1970s.

January 18, 2013

The AIDS Healthcare Foundation is rebranding a chain of specialty pharmacies it recently bought.

LOS ANGELES — The AIDS Healthcare Foundation is rebranding a chain of specialty pharmacies it recently bought.

The AHF, which bought MOMS Pharmacy in August 2012, said it would rebrand the chain as AHF Pharmacy. MOMS is focused exclusively on providing medications and support services to people living with HIV and AIDS. The name change will be effective immediately, but the entire rebranding could take several months due to state pharmacy regulations and the need to replace signage, prescription labeling and other fixtures.

January 18, 2013

Costco has entered the pharmacy benefit management business, according to published reports.

NEW YORK — Costco has entered the pharmacy benefit management business, according to published reports.

In an article in the January 2013 issue of Costco Connection magazine, the club warehouse retailer is promoting the new PBM, Costco Health Solutions, to small business owners. Pharmaceutical industry consultant Adam Fein noted on his blog, Drug Channels, that Costco was seeking to emulate the tactics already used by CVS Caremark, Walgreens and Walmart to drive prescription growth.

January 18, 2013

Pharmacy automation company Innovation has appointed Phil Samples as VP government and professional services, the company said Friday.

JOHNSON CITY, N.Y. — Pharmacy automation company Innovation has appointed Phil Samples as VP government and professional services, the company said Friday.

January 18, 2013

The Food and Drug Administration is allowing Roche to tap its reserves of the flu drug Tamiflu, according to published reports.

NEW YORK — The Food and Drug Administration is allowing Roche to tap its reserves of the flu drug Tamiflu, according to published reports.

Reuters reported that the Swiss drug maker would start selling its reserve stock of the adult formulation of the drug, whose chemical name is oseltamivir.

The FDA has reported spot shortages of the pediatric formulation of the drug, but has said pharmacists can break open the capsules and dissolve it in liquid to create a substitute. Meanwhile, a shortage of the adult formulation has appeared in Canada.

January 17, 2013

Boehringer Ingelheim Pharmaceuticals has enrolled the first patients in its late-stage trial of a treatment for hepatitis C, the drug maker said Thursday.

RIDGEFIELD, Conn. — Boehringer Ingelheim Pharmaceuticals has enrolled the first patients in its late-stage trial of a treatment for hepatitis C, the drug maker said Thursday.

BI Pharmaceuticals is conducting the "HCVerso" trial of an HCV drug that combines faldaprevir, the experimental compound BI 207127 and ribavirin. The company has established trial sites in more than 25 states.

January 17, 2013

The Food and Drug Administraiton has approved a drug for replacing clotting proteins in the blood for conditions in which patients have too little of them.

SILVER SPRING, Md. — The Food and Drug Administraiton has approved a treatment for replacing clotting proteins in the blood for conditions in which patients have too little of them.

The FDA announced the approval of Octapharma's Octaplas, a sterile, frozen solution of pooled human plasma from multiple donors that has been treated with a solvent detergent process.

January 17, 2013

More than 5,000 medicines are under development, of which 70% are potentially the first of their class, according to a new report.

WASHINGTON — More than 5,000 medicines are under development, of which 70% are potentially the first of their class, according to a new report.

January 17, 2013

Rite Aid has obtained 400,000 new seasonal flu shots, which began arriving in stores earlier this week, the retail pharmacy chain said.

CAMP HILL, Pa. — Rite Aid has obtained 400,000 new seasonal flu shots, which began arriving in stores earlier this week, the retail pharmacy chain said Thursday.

The company said it was delivering the shots to areas of need based on actual or anticipated flu activity.

January 16, 2013

An advocacy group focused on a rare lung disorder is working with government authorities to educate patients about the need to get flu shots.

CULVER CITY, Calif. — An advocacy group focused on a rare lung disorder is working with government authorities to educate patients about the need to get flu shots.

The Coalition for Pulmonary Fibrosis said it would partner with the Centers for Disease Control and Prevention to inform patients about the need for immunizations. PF is a disorder with no known cause or cure that causes scarring and deterioration of the lungs, affecting about 128,000 Americans.

January 16, 2013

The Food and Drug Administration has approved an ulcerative colitis drug made by Santarus, the drug maker said.

SAN DIEGO — The Food and Drug Administration has approved an ulcerative colitis drug made by Santarus, the drug maker said.

Santarus announced the approval of Uceris (budesonide) extended-release tablets for mild to active UC. The company plans to launch the drug in March.

January 16, 2013

The Food and Drug Administration has set user fee rates for generic drug companies, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has set user fee rates for generic drug companies, the agency said Wednesday.

The FDA announced that it had published a notice in the Federal Register for companies that make finished dosage forms, meaning drugs in their final form, and active pharmaceutical ingredients, meaning the main ingredients of the drugs.

January 16, 2013

A new app allows people to share their STD statuses with potential partners.

NEW YORK — A new app allows people to share their STD statuses with potential partners.

Giffen Solutions announced the launch of MedXSafe, a new feature to its MedXCom Patient platform. The app allows people to bump phones with a potential partner and exchange contact information as well as their STD status. Giffen emphasized that users choose to share their information and that the app doesn't violate medical confidentiality laws, and only licensed healthcare providers can register to use the MedXCom system.

January 16, 2013

New York is hoping to battle the theft of highly addictive prescription drugs, such as Oxycontin, by stocking pharmacies with fake pill bottles that are fitted with GPS tracking devices, according to published reports.

NEW YORK — New York is hoping to battle the theft of highly addictive prescription drugs, such as Oxycontin, by stocking pharmacies with fake pill bottles that are fitted with GPS tracking devices, according to published reports.

The Washington Post reported that Police Commissioner Raymond Kelly said, in prepared remarks provided before a conference Tuesday in California sponsored by former president Bill Clinton’s foundation, that the initiative was sparked by a series of crimes associated with the black market for prescription painkillers.

January 16, 2013

Specialty drug spend will surpass traditional drug spend by 2018 for commercial plan sponsors, according to a new study.

BRENTWOOD, Tenn. — Specialty drug spend will surpass traditional drug spend by 2018 for commercial plan sponsors, according to a new study.

January 15, 2013

The Generic Pharmaceutical Association has appointed a new officer to head its communications, the industry trade group said Tuesday.

WASHINGTON — The Generic Pharmaceutical Association has appointed a new officer to head its communications, the industry trade group said Tuesday.

The GPhA announced the appointment of Claire Sheahan as VP communications, effective Jan. 22. Sheahan previously worked as SVP and partner of communications firm Fleishman-Hillard, leading the firm's Washington-based healthcare practice.

January 15, 2013

The state supreme court in Alabama ruled that brand-name drug companies could be sued if patients suffer complications from generic versions of their medicines, according to published reports.

NEW YORK — The state supreme court in Alabama ruled that brand-name drug companies could be sued if patients suffer complications from generic versions of their medicines, according to published reports.

According to The New York Times, an Alabama man named Danny Weeks claimed he developed tardive dyskinesia after taking generic versions of Pfizer's acid reflux drug Reglan (metoclopramide). Pfizer acquired rights to the drug when it bought Wyeth in 2009, and generic drug makers Teva and Actavis, now owned by Watson, make generic versions.

January 15, 2013

Drug maker Otsuka Pharmaceuticals can keep generic versions of its schizophrenia drug off the market, according to published reports.

NEW YORK — Drug maker Otsuka Pharmaceuticals can keep generic versions of its schizophrenia drug off the market, according to published reports.

Bloomberg reported that the Supreme Court upheld a ruling that allowed Otsuka to block Canadian generic drug maker Apotex from marketing a version of the antipsychotic Abilify (aripiprazole), which Otsuka co-markets with Bristol-Myers Squibb.

January 15, 2013

A new ad format from health kiosk maker SoloHealth delivers targeted sponsor content that allows consumers to request additional information regarding products or services that will help promote healthy lifestyles, the company said.

ATLANTA — A new ad format from health kiosk maker SoloHealth delivers targeted sponsor content that allows consumers to request additional information regarding products or services that will help promote healthy lifestyles, the company said.

January 15, 2013

A maker of drugs for epilepsy has appointed a new executive.

ROCKVILLE, Md. — A maker of drugs for epilepsy has appointed a new executive.

Supernus Pharmaceuticals announced the appointment of Victor Vaughn as SVP sales, a position in which he will be responsible for leading all the company's sales activities.

January 15, 2013

While replacing a single combination pill for HIV with generics would save the healthcare system money, it could also diminish the effectiveness of treatment, a new study suggests.

NEW YORK — While replacing a single combination pill for HIV with generics would save the healthcare system money, it could also diminish the effectiveness of treatment, a new study suggests.

The study, led by investigators at the Massachusetts General Hospital and Weill Cornell Medical College, and published in the Jan. 15 issue of Annals of Internal Medicine, found $1 billion in potential savings, but the more complicated treatment regimen might result in more patients missing doses and a loss of drug effectiveness.